CanSino Biologics Inc. (CASBF)
OTCMKTS · Delayed Price · Currency is USD
4.900
0.00 (0.00%)
At close: Jul 21, 2025
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of $1.85 billion as of July 25, 2025. Its market cap has increased by 91.28% in one year.
Market Cap
1.85B
Enterprise Value
1.70B
Revenue
119.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.90
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 964.53M to 1.85B, an increase of 91.90%. That is a compound annual growth rate of 10.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 1.85B | 23.84% |
| Dec 31, 2024 | 1.49B | -6.53% |
| Dec 29, 2023 | 1.60B | -54.97% |
| Dec 30, 2022 | 3.55B | -58.11% |
| Dec 31, 2021 | 8.48B | -11.66% |
| Dec 31, 2020 | 9.60B | 469.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 588.81M |
| Glass House Brands | 411.26M |
| Northwest Biotherapeutics | 382.85M |
| CytoDyn | 362.86M |